Tender Details

Country: Poland
Summary: Coagulation Factor Viii Concentrate Containing Von Willebrand Factor for the Treatment of Von Willebrand Disease, in a Ratio of at Least 1 Unit of Von Willebrand Factor to 1 Unit of Clotting Factor...
PLT Ref No: 128657451
Deadline: 07 Nov 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 695250-2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Coagulation factor VIII concentrate containing von Willebrand factor for the treatment of von Willebrand disease, in a ratio of at least 1 unit of von Willebrand factor to 1 unit of clotting factor...
Coagulation factor VIII concentrate containing von Willebrand factor for the treatment of the disease von Willebrand, in a ratio of at least 1 unit of von Willebrand factor to 1 unit of coagulation factor VIII, Parts: 1/3
The subject of the order is the supply of human coagulation factor VIII concentrate containing von Willebrand factor to ensure the continuity of patient treatment. with von Willebrand's disease, in a ratio of at least 1 unit of von Willebrand factor to 1 unit of coagulation factor VIII - hereinafter referred to as "coagulation factor" in accordance with the description of the subject of the contract specified in the terms of reference (SWZ) and on the conditions specified in the designed provisions of the contract (PPU), which constitute an annex to the SWZ.
Part 1: Coagulation factor VIII concentrate containing von Willebrand factor for the treatment of von Willebrand disease, in a ratio of at least 1 unit of von Willebrand factor to 1 unit of coagulation factor VIII.
1. Subject The order is for the supply of human coagulation factor VIII concentrate containing von Willebrand factor to ensure the continuity of treatment of patients with von Willebrand disease, in a ratio of at least 1 unit of von Willebrand factor to 1 unit of coagulation factor VIII - further "clotting factor". in accordance with the requirements specified in the SWZ and PPU in the amount of 3,300,000 IU.
1.1. The activity of von Willebrand factor should be related to the activity of factor VIII in the concentrate less...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Coagulation Factor Viii Concentrate Containing Von Willebrand Factor for the Treatment of Von Willebrand Disease, in a Ratio of at Least 1 Unit of Von Willebrand Factor to 1 Unit of Clotting Factor... - Poland Tender

The NATIONAL BLOOD CENTER, a Government sector organization in Poland, has announced a new tender for Coagulation Factor Viii Concentrate Containing Von Willebrand Factor for the Treatment of Von Willebrand Disease, in a Ratio of at Least 1 Unit of Von Willebrand Factor to 1 Unit of Clotting Factor.... This tender is published on PolandTenders under PLT Ref No: 128657451 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-07.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.